Detalhe da pesquisa
1.
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
Proc Natl Acad Sci U S A
; 121(15): e2322563121, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557192
2.
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Proc Natl Acad Sci U S A
; 120(30): e2221809120, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459541
3.
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Proc Natl Acad Sci U S A
; 120(49): e2314416120, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011559
4.
Do cerebral and somatic tissue oxygen saturation measurements correlate with each other during surgery?
J Clin Monit Comput
; 34(3): 483-490, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31203491
5.
Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader.
J Med Chem
; 67(9): 6938-6951, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687638
6.
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer.
bioRxiv
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562800
7.
PIKfyve controls dendritic cell function and tumor immunity.
bioRxiv
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464258
8.
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
bioRxiv
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464081
9.
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464251
10.
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.
bioRxiv
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586029
11.
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies.
bioRxiv
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328238
12.
Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis.
Transl Androl Urol
; 10(1): 374-383, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532325
13.
Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
Clin Genitourin Cancer
; 19(2): 155-161, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288452
14.
Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis.
Front Pharmacol
; 12: 707271, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34603020
15.
Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study.
Transl Androl Urol
; 10(2): 734-740, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718075
16.
PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer.
Front Immunol
; 12: 705086, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777336
17.
Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis.
Transl Androl Urol
; 9(5): 2094-2106, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33209672
18.
A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma.
Transl Androl Urol
; 9(2): 462-472, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420152
19.
A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma.
Urol Oncol
; 38(7): 641.e19-641.e29, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389428
20.
Effect of goal-directed fluid therapy based on both stroke volume variation and delta stroke volume on the incidence of composite postoperative complications among individuals undergoing meningioma resection.
Chin Med J (Engl)
; 136(16): 1990-1992, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370235